Patient U1 presented with a multi-system disorder and significant myopathy; however, due to unremarkable brain imaging and a non-diagnostic muscle biopsy (Supplementary Fig. 1), the diagnosis of POMGNT1-related dystroglycanopathy was delayed. Here, POMGNT1 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.